To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 622.00 |
Bid | 620.00 |
Ask | 624.00 |
Change | -5.00 (-0.80%) |
Volume | 49,003 |
Open | 628.00 |
High | 628.00 |
Low | 620.00 |
Prev. Close | 627.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.77m |
Market Capitalisation | £234.92m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 32 |
---|---|
Vol. Sold | 25,906 |
Sold Value | £161.93k |
Vol. Bought | 10,605 |
Bought Value | £66.57k |
PE Ratio | 37.04586 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.534% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 16:35:01 | 622.00 | 53 | Sell* | 622.00 | 624.00 | 329.66 | UT Uncrossing Trade |
24-Apr-24 | 16:26:58 | 623.777 | 623 | Buy* | 620.00 | 626.00 | 3,886 | O Ordinary |
24-Apr-24 | 16:25:21 | 620.00 | 1,000 | Sell* | 620.00 | 626.00 | 6,200 | A Automatic Execution |
24-Apr-24 | 15:51:56 | 622.5826 | 422 | Sell* | 620.00 | 626.00 | 2,627 | O Ordinary |
24-Apr-24 | 15:26:00 | 626.5856 | 2,004 | Sell* | 624.00 | 630.00 | 12.56k | O Ordinary |
24-Apr-24 | 14:58:19 | 626.295 | 1,824 | Buy* | 620.00 | 630.00 | 11.42k | O Ordinary |
24-Apr-24 | 14:39:21 | 628.00 | 4,606 | Buy* | 620.00 | 628.00 | 28.93k | O Ordinary |
24-Apr-24 | 14:39:13 | 628.00 | 829 | Sell* | 628.00 | 634.00 | 5,206 | A Automatic Execution |
24-Apr-24 | 14:39:13 | 628.00 | 500 | Buy* | 620.00 | 628.00 | 3,140 | A Automatic Execution |
24-Apr-24 | 14:38:58 | 625.0752 | 10,394 | Sell* | 624.00 | 628.00 | 64.97k | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |